长江生命CK Life Sciences  
长江生命科技集团有限公司 (港交所：0775)，简称长江生命
科技，于港交所的主板上市，为长江集团成员之一，主席是长江集团主席李嘉诚先生长子李泽钜先生。公司主要从事生物科技产品的研发、商品化、推广及销售业务。曾经从世界经济论坛获得2004年度“科技先驱”公司奖项。公司在2000年成立，在2002年于创业板上市，当时上市编号为 (港交所：8222)，2008年移至主板上市。

CK Life Sciences Int'l., (Holdings) Inc. (stock code: 0775) is listed on the Stock Exchange of Hong Kong. Bearing the mission of improving the quality of life, CK Life Sciences is engaged in the business of research and development, commercialization, marketing and sale of health and agriculture related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. A number of inventions have been granted patents by the US Patent and Trademark Office. CK Life Sciences is a member of the Cheung Kong Group.